Does FOTEMUSTINE Cause Malignant neoplasm progression? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with FOTEMUSTINE. This represents 2.7% of all adverse event reports for FOTEMUSTINE.
7
Reports of Malignant neoplasm progression with FOTEMUSTINE
2.7%
of all FOTEMUSTINE reports
1
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From FOTEMUSTINE?
Of the 7 reports, 1 (14.3%) resulted in death, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOTEMUSTINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does FOTEMUSTINE Cause?
Off label use (66)
Disease progression (38)
Acute myeloid leukaemia (30)
Thrombocytopenia (29)
Mucosal inflammation (25)
Neutropenia (24)
Product use in unapproved indication (23)
Platelet count decreased (22)
Neutrophil count decreased (20)
Septic shock (20)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which FOTEMUSTINE Alternatives Have Lower Malignant neoplasm progression Risk?
FOTEMUSTINE vs FRAMYCETIN
FOTEMUSTINE vs FREMANEZUMAB
FOTEMUSTINE vs FREMANEZUMAB-VFRM
FOTEMUSTINE vs FROVATRIPTAN
FOTEMUSTINE vs FRUCTOSE